Laboratory Corporation of America

Labcorp helps doctors and hospitals diagnose diseases and monitor health. Its tests guide treatment decisions for patients and support drug development for pharmaceutical companies. Everyday users benefit from faster, more accurate test results and easier access to health information.

Lab Work, Simplified: Products and Services

• Diagnostics Laboratories (Dx): Routine and specialty lab tests for patients and doctors; 78% of 2025 revenue.
• Biopharma Laboratory Services (BLS): Lab support for drug trials and research; 22% of 2025 revenue.
• Digital Health Tools: Online test ordering, results access, and AI-powered test selection for providers and patients.
• Patient Service Centers: Over 2,200 locations for sample collection and health screenings across the U.S. and Canada.
• Clinical Trial Management: Digital platforms and global labs supporting pharmaceutical and biotech companies worldwide.

Growth Spurts: Expansion and Acquisitions

• Acquired BioReference Health and Community Health Systems in 2025 to expand U.S. lab presence.
• Purchased a 15% stake in SYNLAB (Europe) in 2025, increasing international reach.
• Launched over 130 new tests in 2025, including Alzheimer’s and cancer diagnostics.
• Announced plans to acquire Empire City Laboratories and Parkview Health System lab assets in 2025.
• Formed 13 new health system partnerships in 2025 to broaden specialty testing access.

Why Labcorp Stands Out

Labcorp operates one of the largest automated lab networks worldwide, serving over 100 countries. Its integrated approach combines diagnostics and drug development, supporting both healthcare providers and pharmaceutical companies. Advanced digital tools and specialty testing in areas like oncology and neurology set it apart from competitors.

Five Things You Need to Know

• Revenue was $13.95 billion in 2025, up 7.2% from 2024.
• Diagnostics (Dx) made up 78% of 2025 revenue; Biopharma (BLS) 22%.
• Operating income reached $1.38 billion in 2025, up 27.4% year-over-year.
• Labcorp performed over 750 million tests globally in 2025.
• International sales were 13.5% of total revenue in 2025.

Bottom Line

Labcorp has evolved through acquisitions, innovation, and global expansion. Its diversified services and technology investments help it adapt to changing healthcare needs.